Medicine. Stroke--tPA and the clinic.
Published
Journal Article
Clinical trial results are not always rapidly incorporated into routine medical practice. This Policy Forum describes a variety of barriers that have impeded the more widespread use of thrombolytic therapy (tPA, tissue plasminogen activator) for selected patients with acute ischemic stroke. These barriers are not insurmountable but will require a concerted effort to overcome.
Full Text
Duke Authors
Cited Authors
- Marler, JR; Goldstein, LB
Published Date
- September 2003
Published In
Volume / Issue
- 301 / 5640
Start / End Page
- 1677 -
PubMed ID
- 14500967
Pubmed Central ID
- 14500967
Electronic International Standard Serial Number (EISSN)
- 1095-9203
International Standard Serial Number (ISSN)
- 0036-8075
Digital Object Identifier (DOI)
- 10.1126/science.1090270
Language
- eng